Guardant Health, Inc.·4

Jun 22, 5:51 PM ET

Gadde Vijaya 4

4 · Guardant Health, Inc. · Filed Jun 22, 2026

Research Summary

AI-generated summary of this filing

Updated

Guardant Health (GH) Director Gadde Vijaya Exercises Options, Receives RSUs

What Happened

  • Director Gadde Vijaya exercised/converted a derivative (reported as Code M) covering 4,203 shares and the same 4,203-derivative position was reported as disposed (both at $0). In addition, she was shown as acquiring a grant/award of 2,711 restricted stock units (RSUs) at $0. The transactions are reported for 2026-06-17; the Form 4 was filed on 2026-06-22.

Key Details

  • Transaction date: June 17, 2026. Form 4 filed: June 22, 2026 (filed 5 calendar days / 3 business days after the transaction).
  • Reported amounts/prices: 4,203 shares (Exercise/Conversion, $0); 4,203 shares (Disposed—derivative, $0); 2,711 RSUs granted (Acquired, $0).
  • Reported dollar totals on the Form 4: $0 for each line (these reflect exercise/grant terms; market value would require multiplying by the stock price on the transaction date).
  • Shares owned after transaction: Not specified in the information provided in this summary (not disclosed here).
  • Footnotes from the filing:
    • F1: The RSU award vested in full on the date of the 2026 Annual Meeting (June 17, 2026).
    • F2: Not applicable for Restricted Stock Units.
    • F3: The RSU award vests in full on the one‑year anniversary of the grant date (June 17, 2026) or at the Company’s next annual meeting, whichever is earlier.
  • Timeliness: The Form 4 appears to have been filed later than the typical 2-business-day reporting window.

Context

  • Derivative transactions: The filing shows an exercise/conversion of a derivative and a corresponding disposition of the derivative position; the filing does not report an open‑market sale of underlying common stock. Transactions showing $0 commonly reflect awards or zero‑strike arrangements; to assess dollar impact, multiply the underlying shares by Guardant Health’s market price on June 17, 2026.
  • RSUs: The 2,711 RSUs are reported with vesting commentary (see footnotes); vested RSUs typically convert to shares subject to any tax withholding rules before final delivery.
  • No inference about intent or company outlook should be drawn from these administrative or compensation‑related filings alone.

Insider Transaction Report

Form 4
Period: 2026-06-17
Gadde Vijaya
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2026-06-17+4,20328,517 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F2]
    2026-06-174,2030 total
    Exercise: $0.00Common Stock (4,203 underlying)
  • Award

    Restricted Stock Units

    [F3][F2]
    2026-06-17+2,7112,711 total
    Exercise: $0.00Common Stock (2,711 underlying)
Footnotes (3)
  • [F1]The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026.
  • [F2]Not applicable for Restricted Stock Units.
  • [F3]The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier.
Signature
/s/ John G. Saia, as attorney-in-fact for Vijaya Gadde|2026-06-22

Documents

1 file
  • 4
    wk-form4_1782165106.xmlPrimary

    FORM 4